A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

Trial Identifier:	D2287R00198
Sponsor:	AstraZeneca
NCTID::	NCT06422663
Start Date:	March 2024
Primary Completion Date:	February 2025
Study Completion Date:	February 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China, Shanghai	Shanghai, China, 20000

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.